Showing results 20 to 39 of 56
< previous
next >
Issue Date | Title | Author(s) |
2015-06-01 | Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection | Arora, S; Haghi, M; Loo, CY; Traini, D; Young, PM; Jain, S |
2016-10-02 | Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation | Pozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F |
2020-04 | Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells. | Grau-Bartual, S; Al-Jumaily, AM; Young, PM; Traini, D; Ghadiri, M |
2017-04-21 | The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells | Ghadiri, M; Young, PM; Jarolimek, W; Grau, GER; Oliver, BGG; Traini, D |
2014 | Effect of Particle Size and Excipients on the Uptake of Beclomethasone Dipropionate-Pressurized Metered Dose Inhalers After Deposition on Calu-3 Respiratory Epithelia | Haghi, M; Traini, D; Lewis, DA; Forbes, B; Colombo, P; Young, PM; Dalby RN, Byron PR, Peart J, Suman JD, Young PM, Traini D |
2011-09-01 | Epithelial profiling of antibiotic controlled release respiratory formulations | Ong, HX; Traini, D; Bebawy, M; Young, PM |
2015-03-30 | Evolved gas analysis during thermal degradation of salbutamol sulphate | Sonvico, F; Coleman, V; Traini, D; Young, PM |
2013-11-01 | Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler | Haghi, M; Traini, D; Postma, DS; Bebawy, M; Young, PM |
2015-05-05 | The formulation of a pressurized metered dose inhaler containing theophylline for inhalation | Zhu, B; Haghi, M; Goud, M; Young, PM; Traini, D |
2014-01-01 | The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler | Saadat, A; Zhu, B; Haghi, M; King, G; Colombo, G; Young, PM; Traini, D |
2021-08-05 | How Do Mechanics Guide Fibroblast Activity? Complex Disruptions during Emphysema Shape Cellular Responses and Limit Research. | Leslie, MN; Chou, J; Young, PM; Traini, D; Bradbury, P; Ong, HX |
2015-01-01 | Implications and emerging control strategies for ventilator-associated infections | Loo, CY; Lee, WH; Young, PM; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R |
2014-01-01 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation | Ong, HX; Benaouda, F; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Forbes, B; Young, PM |
2015-07-03 | In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation | Trotta, V; Lee, WH; Loo, CY; Haghi, M; Young, PM; Scalia, S; Traini, D |
2015-05-26 | Inhalable tranexamic acid for haemoptysis treatment | Haghi, M; Van Den Oetelaar, W; Moir, LM; Zhu, B; Phillips, G; Crapper, J; Young, PM; Traini, D |
2012-01 | Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia | Ong, HX; Cipolla, DC; Gonda, I; Traini, D; Bebawy, M; Agus, H; Young, PM; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
2016-01-01 | An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy | Arora, S; Kappl, M; Haghi, M; Young, PM; Traini, D; Jain, S |
2012-12-01 | Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia | Ong, HX; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Agus, H; Young, PM |
2012-03-01 | Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles | Haghi, M; Salama, R; Traini, D; Bebawy, M; Young, PM |
2015-08-03 | Mono- and Cocultures of Bronchial and Alveolar Epithelial Cells Respond Differently to Proinflammatory Stimuli and Their Modulation by Salbutamol and Budesonide | Haghi, M; Hittinger, M; Zeng, Q; Oliver, B; Traini, D; Young, PM; Huwer, H; Schneider-Daum, N; Lehr, CM |